(Q35854145)

10 August 2017

A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice (English)

1 reference

10 August 2017

0 references

5

Wylie Burke

1 reference

10 August 2017

1

David L Veenstra

1 reference

10 August 2017

Joshua A Roth

2

1 reference

10 August 2017

Louis P Garrison

series ordinal

3

1 reference

10 August 2017

Scott D Ramsey

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

10 August 2017

1 reference

10 August 2017

12

1 reference

10 August 2017

11

1 reference

10 August 2017

686-693

1 reference

https://scigraph.springernature.com/pub.10.1097/gim.0b013e3181eff533

10 August 2017

0 references

cites work

Stakeholder perspectives on a risk-benefit framework for genetic testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

The genomic applications in practice and prevention network

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

New methods of analysing cost effectiveness

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Genomic tests for ovarian cancer detection and management

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Numeracy skill and the communication, comprehension, and use of risk-benefit information

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits)

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Pharmacogenetics of antidepressant medication intolerance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Ethical, legal, and social implications of genomic medicine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Genetic test evaluation: information needs of clinicians, policy makers, and the public

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Handling uncertainty in cost-effectiveness models

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

The efficacy of diagnostic imaging

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Development of the 21-gene assay and its application in clinical practice and clinical trials

11 July 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Warfarin and pharmacogenomic testing: the case for restraint

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Risks and benefits of risk-management plans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

The risk-benefit balance in the United States: who decides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Defining the balance of risk and benefit in the era of genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

What is the clinical utility of genetic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Categorizing genetic tests to identify their ethical, legal, and social implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Current assessment of risk-benefit by regulators: is it time to introduce decision analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181EFF533

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312796

Oversight of US genetic testing laboratories

24 September 2018

1 reference

12 December 2020

Coverage options for promising technologies: Medicare's 'coverage with evidence development'

1 reference

12 December 2020

Balancing modern medical benefits and risks

1 reference

12 December 2020

Risks and benefits in health care: the view from economics

1 reference

12 December 2020

New USPSTF guidelines: integrating into clinical practice. US Preventive Services Task Force

1 reference

12 December 2020

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

12 December 2020

Angioplasty and stenting of the cervical carotid artery with embolic protection of the cerebral circulation

1 reference

12 December 2020

Quantitative decision analysis: a work in progress

1 reference

12 December 2020

Personalized medicine in the era of genomics

1 reference

12 December 2020

Defining purpose: a key step in genetic test evaluation

1 reference

12 December 2020

10.1097/GIM.0B013E3181EFF533

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

20808229

1 reference